MicroTransponder Announces Development Agreement with Paragon Innovations to Design an External Controller for SAINT™ System
Dallas, TX, September 29, 2009 --(PR.com)-- MicroTransponder Inc., a privately-held medical device company developing a suite of wireless neuroneuroprostheses, has just announced that it has entered into a development agreement with Paragon Innovations, Inc. to design a rechargeable, battery-powered, external controller for the SAINT™ system. The external controller will be worn by the patient and power the implant via RF energy.
“Paragon Innovations was chosen by us as a development partner, due to their years of experience with medical device development, and their development and project management tools,” stated CTO Scott Armstrong. “We look forward to a long lasting relationship with Paragon Innovation,” he continued.
The SAINTTM unit (Subcutaneous Arrangement of Implantable Neural Transponders) is in development to treat chronic pain. It eliminates the need to have batteries or wires inside of the body. This platform technology will be coupled to an external controller, which can be worn like an armband, and will provide the power and stimulus parameters for the device.
“Working with MicroTransponder allows us to leverage our experience in medical and wireless device design. Over $20 Billion is spent each year treating chronic pain and MicroTransponder is leading the field to develop wireless medical technology to treat chronic pain,” said Michael Wilkinson, CEO of Paragon Innovations, Inc. “We are pleased to add our engineering and design skills to a device that will transform the future of pain management.”
About MicroTransponder, Inc.
MicroTransponder (www.microtransponder.com) is developing a wireless neurostimulation system for the treatment of chronic pain and several other neurological indications. The minimally invasive device will provide relief from chronic pain without requiring an implanted battery or wires. The company is finalizing R&D on the device and accumulating data toward FDA clearance. MicroTransponder also is adapting the system for Vagus Nerve Stimulation to create a pipeline of innovative treatments for other neurological indications, including stroke rehabilitation, tinnitus, and autism.
About Paragon Innovations
Paragon Innovations, Inc. is a leading engineering and product development service provider specializing in medical devices, video displays, portable wireless devices, and a variety of other markets. Founded in 1990, Paragon has worked with Fortune 500 companies, as well as startup ventures, to provide turn-key electrical, mechanical and industrial design engineering services from concept development to market launch. For more information, visit www.paragoninnovations.com.
###
“Paragon Innovations was chosen by us as a development partner, due to their years of experience with medical device development, and their development and project management tools,” stated CTO Scott Armstrong. “We look forward to a long lasting relationship with Paragon Innovation,” he continued.
The SAINTTM unit (Subcutaneous Arrangement of Implantable Neural Transponders) is in development to treat chronic pain. It eliminates the need to have batteries or wires inside of the body. This platform technology will be coupled to an external controller, which can be worn like an armband, and will provide the power and stimulus parameters for the device.
“Working with MicroTransponder allows us to leverage our experience in medical and wireless device design. Over $20 Billion is spent each year treating chronic pain and MicroTransponder is leading the field to develop wireless medical technology to treat chronic pain,” said Michael Wilkinson, CEO of Paragon Innovations, Inc. “We are pleased to add our engineering and design skills to a device that will transform the future of pain management.”
About MicroTransponder, Inc.
MicroTransponder (www.microtransponder.com) is developing a wireless neurostimulation system for the treatment of chronic pain and several other neurological indications. The minimally invasive device will provide relief from chronic pain without requiring an implanted battery or wires. The company is finalizing R&D on the device and accumulating data toward FDA clearance. MicroTransponder also is adapting the system for Vagus Nerve Stimulation to create a pipeline of innovative treatments for other neurological indications, including stroke rehabilitation, tinnitus, and autism.
About Paragon Innovations
Paragon Innovations, Inc. is a leading engineering and product development service provider specializing in medical devices, video displays, portable wireless devices, and a variety of other markets. Founded in 1990, Paragon has worked with Fortune 500 companies, as well as startup ventures, to provide turn-key electrical, mechanical and industrial design engineering services from concept development to market launch. For more information, visit www.paragoninnovations.com.
###
Contact
MicroTransponder Inc.
Jordan Curnes
214-770-0935
www.microtransponder.com
Jordan Curnes
214-770-0935
www.microtransponder.com
Contact
Categories